New method of treating diabetes

An artificial pancreas, continuously controlling blood glucose levels, provides timely insulin, which is more effective than traditional insulin injections in controlling type 1 diabetes. This is the discovery of scientists. from the Montreal Clinical Research Institute (IRCM), Canada.

The IRCM study published in the Journal of the Canadian Medical Association on January 28 showed that tests conducted for type 1 diabetics showed that the artificial pancreas had two hormones that improved by 15%. Blood sugar levels and lower the risk of hypoglycemia up to 8 times compared with current insulin supplementation methods.

The artificial pancreas system is built on the basis of intelligent algorithms that regularly control changes in blood sugar levels of patients to recalculate the amount of insulin needed.

According to traditional insulin supplementation methods, diabetic patients often have to check their own blood sugar to control insulin intake.

Picture 1 of New method of treating diabetes

According to the researchers, in fact, about two-thirds of the patients do not do this.

The artificial pancreas can meet this requirement while lowering the risk of hypoglycemia, the most dangerous condition for diabetics and is the most common adverse effect in insulin therapy.

Besides, artificial pancreas can distribute glucogon, which helps increase blood sugar levels when they are too low.

Type 1 diabetes is a disease that occurs when the body does not produce enough insulin, leading to dangerous high blood sugar levels.

Controlling blood sugar by insulin injections is the key to preventing high blood sugar related complications such as blindness or kidney failure.

Treatment also contributes to preventing insulin reduction in the blood - a condition that occurs when blood sugar is too low can cause confusion and disorientation.

IRCM researchers said they will conduct clinical trials to test the effects of the artificial pancreas system over a longer period of time and across all age groups.

This finding is judged to have the potential to significantly improve diabetes control and ensure patient safety during treatment.